SCHEMBL4145583

SCHEMBL4145583

CCCC(O)C(CO)N(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.48
▸ SPHK1 Q9NYA1 3/20 0.42
▸ SPHK2 Q9NRA0 2/20 0.42
▸ CETP P11597 2/20 0.42
▸ TSHR P16473 1/20 0.39
▸ AOC3 Q16853 1/20 0.35
▸ CYP2D6 P10635 2/20 0.33
▸ GMNN O75496 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ THPO P40225 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ UBE2N P61088 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630183 0.85 SPHK1 (0.52) LMNASPHK1SPHK2CETPCYP2D6
SCHEMBL18249947 0.83 LMNA (0.44) LMNASPHK1SPHK2CETPTSHR
SCHEMBL21428085 0.83 SPHK1 (0.55) LMNASPHK1SPHK2CETPCYP2D6
SCHEMBL21636787 0.83 SPHK1 (0.55) LMNASPHK1SPHK2CETPCYP2D6
SCHEMBL15057401 0.83 SPHK1 (0.55) LMNASPHK1SPHK2CETPCYP2D6
Hydrochloric Acid SCHEMBL7612591 0.81 SPHK1 (0.53) LMNASPHK1SPHK2CETPCYP2D6
SCHEMBL28056561 0.81 LMNA (0.43) LMNASPHK1SPHK2CETPTSHR
SCHEMBL25058928 0.80 SPHK2 (0.40) LMNASPHK1SPHK2CETPTSHR
SCHEMBL15750870 0.79 LMNA (0.40) LMNASPHK1SPHK2CETPTSHR
SCHEMBL11213426 0.73 SPHK2 (0.35) SPHK1SPHK2CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230372207-A1 CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN KAO CORPORATION (JP) 2023-11-23 — — US disclosed
US-20230372207-A1 CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN KAO CORPORATION (JP) 2023-11-23 — — US disclosed
US-11730686-B2 Cosmetic skincare compositions THE BOOTS COMPANY PLC (GB) 2023-08-22 — — US disclosed
US-11730686-B2 Cosmetic skincare compositions THE BOOTS COMPANY PLC (GB) 2023-08-22 — — US disclosed
WO-2022071574-A1 CARBONATED AEROSOL FOR TOPICAL USE 花王株式会社 2022-04-07 — — WO disclosed
WO-2020250966-A1 EMULSION COMPOSITION 花王株式会社 2020-12-17 — — WO disclosed
US-9694076-B2 Vesicle composition KAO CORPORATION (JP) 2017-07-04 — — US disclosed
US-9694076-B2 Vesicle composition KAO CORPORATION (JP) 2017-07-04 — — US disclosed
CN-106317369-A Aqueous polyurethane resin dispersion and use thereof 宇部兴产株式会社 2017-01-11 — — CN disclosed
US-20160166698-A1 VESICLE COMPOSITION KAO CORPORATION (JP) 2016-06-16 — — US disclosed
US-8178584-B2 Sphingosines, fatty acid, and oil; improved stability and feel to skin KAO CORPORATION (JP) 2012-05-15 — — US disclosed
US-8178584-B2 Sphingosines, fatty acid, and oil; improved stability and feel to skin KAO CORPORATION (JP) 2012-05-15 — — US disclosed
US-20120108661-A1 EMULSIFIED COMPOSITION KAO CORPORATION (JP) 2012-05-03 — — US disclosed
US-20120108661-A1 EMULSIFIED COMPOSITION KAO CORPORATION (JP) 2012-05-03 — — US disclosed
US-20110263714-A1 Reverse Vesicle KAO CORPORATION (JP) 2011-10-27 — — US disclosed
US-20110263714-A1 Reverse Vesicle KAO CORPORATION (JP) 2011-10-27 — — US disclosed
US-20100311836-A1 OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION KAO CORPORATION (JP) 2010-12-09 — — US disclosed
US-20100311836-A1 OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION KAO CORPORATION (JP) 2010-12-09 — — US disclosed
US-7846969-B2 Ceramide emulsions KAO CORPORATION (JP) 2010-12-07 — — US disclosed
US-7846969-B2 Ceramide emulsions KAO CORPORATION (JP) 2010-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230372207-A1 CARBONATED AEROSOL EXTERNAL PREPARATION FOR SKIN CERT1, CERS2, SGMS2 LMNA 390/4885SPHK1 25/4885SPHK2 30/4885
US-20160166698-A1 VESICLE COMPOSITION SGMS1, EXOSC10, SGMS2 LMNA 3672/4885SPHK1 56/4885SPHK2 90/4885
US-20100311836-A1 OIL-IN-WATER EMULSIFIED COSMETIC COMPOSITION CERT1, SGMS1, DEGS1 LMNA 600/4885SPHK1 17/4885SPHK2 31/4885
US-20120108661-A1 EMULSIFIED COMPOSITION CERT1, S1PR4, S1PR3 LMNA 1152/4885SPHK1 15/4885SPHK2 19/4885
US-20110263714-A1 Reverse Vesicle SGMS1, EXOSC10, SGMS2 LMNA 380/4885SPHK1 63/4885SPHK2 108/4885
US-11730686-B2 Cosmetic skincare compositions SPHK1, SPHK2, S1PR2 LMNA 1281/4885SPHK1 1/4885SPHK2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback